Coltuximab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free (A323367)

Coltuximab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free

Recombinant human monoclonal antibody to CD19.

ELISA, FACS, Functional Assay, In Vivo

Human, Cynomolgus Macaque

Human

Monoclonal

IgG1

kappa

Protein A affinity chromatography.

Reconstitution dependent.

> 90% (by SDS-PAGE and SEC-HPLC).

Lyophilized

Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!

Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

150 kDa TGF-beta-1-binding protein, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7, CD109, CD109 antigen, CPAMD7, Differentiation antigen CD19, p180, Platelet-specific Gov antigen, r150, T-cell surface antigen Leu-12